Carton (Carton01)
Nelarabine Injection
Product Images NDC 81927-375
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 81927-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Carton02)
Label (Label01)
Nelarabine is an injection used for intravenous infusion only with a concentration of 250mg/50mL. It comes in a single dose vial and any unused portion should be discarded. Each milliliter contains 5 mg of nelarabine and it contains no preservative. The drug must not be diluted and stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is manufactured by AqVida GmbH, Dassow, Germany and distributed by Shorla Oncology Inc., Cambridge, MA 02142, USA. Dosage information should be seen on the package insert.*
Structure (Structure001)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
